Brian Zumbolo Joins the Schreiner Group Team
The experienced manager will head the company’s US plant.
Schreiner Group, who specializes in labels for the pharmaceutical industry, is hiring Brian Zumbolo as the new president of its US plant in Blauvelt, NY. The position had become vacant because the previous manager, Gene Dul, had decided to retire after 15 successful years.
In the past, he has already worked in Schreiner Group's two most important markets, healthcare and mobility, most recently for a supplier in the automotive industry. He has experience in developing new markets, in acquisitions, in driving customer specifications, and in developing strong teams. For six years, he had led the Asia-Pacific business of a major US company from China.
"Schreiner Group has performed very well in the US over the past few years—now, there is the opportunity to take the business to a new level of growth and expansion," says Zumbolo. "I believe Schreiner Group still has great market potential in the United States. In the future, I see our potential as equaling that of the Schreiner Group business in Europe."
Newron, Myung In Pharm Form Partnership Centered Around Treating Schizophrenia in South Korea
January 14th 2025The license agreement will feature an upcoming Phase III trial and—depending on results—the development, manufacturing, and commercialization of evenamide as a potential treatment option.
Machine Health in Pharmaceutical Production
December 2nd 2024Predictive maintenance in pharmaceutical production can help reduce downtime and increase efficiency. Grundfos Machine Health (GMH) uses artificial intelligence (AI)-driven wireless sensors to monitor motor health in real-time, identifying potential issues. This approach not only reduces maintenance costs but also ensures compliance with industry standards.
